SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,828,000 | +186.1% | 11,400 | +74.5% | 0.37% | +76.8% |
| Q1 2020 | $639,000 | -37.4% | 6,532 | -30.1% | 0.21% | -48.8% |
| Q4 2018 | $1,020,000 | -13.7% | 9,350 | +27.7% | 0.41% | +0.5% |
| Q3 2018 | $1,182,000 | +2.3% | 7,320 | -16.2% | 0.41% | -7.2% |
| Q2 2018 | $1,155,000 | -50.5% | 8,740 | -72.3% | 0.44% | -60.8% |
| Q1 2018 | $2,335,000 | +106.6% | 31,520 | +55.2% | 1.13% | +73.8% |
| Q4 2017 | $1,130,000 | +122.0% | 20,305 | +81.0% | 0.65% | +103.4% |
| Q3 2017 | $509,000 | +53.3% | 11,220 | +107.6% | 0.32% | -24.0% |
| Q3 2016 | $332,000 | – | 5,405 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |